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Initial reports
In the first of two successive milestone papers from Brinster's laboratory, Brinster and Zimmerman (1994) demonstrated that microinjection of a heterogeneous mouse testis cell suspension directly into the seminiferous tubules of a genetically sterile mouse resulted in donor spermatogenesis in the recipient. In addition to the mutant recipients, normal male mice treated with 40 mg kg -1 of the chemotherapeutic agent busulfan approximately 4 weeks before transplantation were also used as recipients. At this dose, busulfan destroys nearly all endogenous spermatogonial stem cells, thereby abolishing spermatogenesis within the testis and creating space on the basal surface of the tubules for transplanted stem cells to seed and develop. The lack of germ cells also facilitates the injection procedure, as there is less resistance to the flow of the germ cell suspension through the testis.
Since a small number of endogenous stem cells survive busulfan treatment and will re-initiate spermatogenesis, the busulfan-treated recipient will develop spermatogenesis simultaneously from both the transplanted and endogenous stem cells. Brinster and Zimmerman (1994) used donor mice transgenic for the bacterial Lac Z gene to distinguish donor-derived spermatogenesis from recovering endogenous spermatogenesis. The resulting donor spermatogenesis was authenticated by expression of the reporter gene and subsequent staining with X-Gal. The use of donor transgenic animals carrying the bacterial Lac Z gene is still widely used as a method to verify donor-derived spermatogenesis.
In the second transplantation paper, Brinster and Avarbock (1994) showed that recipient male mice that had been transplanted with testicular cells carrying the bacterial Lac Z gene were fertile and that the Lac Z reporter gene was inherited by successive generations. Some transplant recipients passed on the Lac Z gene to 80% of their progeny. In essence, Brinster's laboratory had pioneered a novel transgenic technology.
The successful demonstration of spermatogonial transplantation and subsequent proliferation and differentiation of the transplanted cells came as a surprise to reproductive scientists. The demonstration that cells introduced into the seminiferous tubule lumen could initiate and maintain spermatogenesis appeared not to be in agreement with the finding that spermatogonia are localized to the basal compartment of the tubules. Spermatogonial stem cells, once injected into the lumen of the seminiferous tubules, must translocate from the lumen to the basal compartment of the seminiferous tubules to produce qualitatively normal spermatogenesis and, in doing so, must traverse extensive Sertoli cell-Sertoli cell tight junctions in a direction opposite to that in which germ cells normally move in the testis. The molecular mechanisms regulating the recognition of the injected stem cells and their translocation to the basal surface of the tubule still remains to be elucidated. The next report was that of Jiang and Short (1995) who demonstrated the successful transplantation of rat testicular cells into the seminiferous tubules of rats that had been treated with busulfan. There was no positive identification that the donor cells had colonized seminiferous tubules owing to the lack of a selectable marker. Recipient spermatogenesis was characterized as intraluminal since portions of tubules with characteristic cell associations were observed in the lumen of complete tubules supporting spermatogenesis -essentially a partial tubule within a complete tubule. The intraluminal spermatogenesis was stage-synchronized with the spermatogenesis occurring within the complete tubule. How could such intraluminal spermatogenesis occur? It seemed that intraluminal spermatogenesis could develop if peritubular cells, Sertoli cells and stem cells were injected as an aggregate.
Interspecies (xenogeneic) transplantation
In 1996, Brinster's laboratory reported yet another major development in spermatogonial stem cell transplantation. Clouthier et al. (1996) reported that xenogeneic transplantation had been performed successfully. Rat testis cells that were microinjected into the testes of immunocompromised animals (nude and severe combined immunodeficient mice) developed and completed spermatogenesis. Spermatozoa with the characteristic head shape of rat spermatozoa were found in the epididymides of recipient mice months after transplantation. This finding was significant since the prevailing paradigm was that the Sertoli cells, which are essential for the process of spermatogenesis, would not fully 'support' germ cells with different developmental timing and morphology. The success of rat to mouse transplants led to a re-evaluation of the role of the Sertoli cell in terms of its requirements to support germinal cells. Apparently, the Sertoli cell-germ cell interactions during spermatogenesis were more plastic than previously believed.
Light and electron microscopic studies were undertaken to evaluate the morphology of the mouse to mouse and rat to mouse stem cell transplants . Seminiferous tubules with normal spermatogenic cell associations were found in both types of transplants. In rat to mouse transplants, rat germ cells developed associations with mouse Sertoli cells. However, spermatogenesis from both the syngeneic and xenogeneic transplants were not always qualitatively or quantitatively complete in transplanted animals, as elongated spermatids were often missing or deformed. In regions lacking spermatogenesis, Sertoli cells phagocytosed elongated spermatids, indicating that Sertoli cells not supporting spermatogenesis develop surface features that can recognize elongated spermatids and remove them. demonstrated that a testis cell mixture could be frozen for extended periods before transplantation and develop spermatogenesis subsequently. The journal cover labelled the transplanted cells as 'immortal sperm' since it was now possible to store stem cells indefinitely and produce unlimited spermatozoa from spermatogonial stem cells. The implications of this work in zoology, basic science and medicine are tremendous. Presumably, the germ line of valuable research and agricultural animals can be frozen and reintroduced to multiple recipients at a later time, each of which would be capable of passing on the genes of the donor. In addition, the success of xenogeneic transplants from Brinster's laboratory indicates that the germ line of endangered species that die before sexual maturity or are too old to breed successfully could be rescued and introduced into a closely related species. The resulting gametes could be harvested to produce offspring of the endangered species via various assisted reproductive technologies. Furthermore, the report of also raised an important medical question as to whether men likely to lose spermatogenic function after chemotherapy or radiotherapy should have a testicular biopsy taken and cryopreserved for later reintroduction into their testes to restore spermatogenesis. Ogawa et al. (1997) published a thorough report on the techniques and methods used in spermatogonial stem cell 184 D. S. Johnston et al. First report of spermatogenesis after germ cell transplantation Brinster and Zimmerman, 1994 Germline transmission of donor haplotype after transplantation Brinster and Avarbock, 1994 First report of xenogeneic transplantation Clouthier et al., 1996 Spermatogenesis from cryogenically preserved spermatogonial stem cells Detailed description of transplantation techniques Ogawa and Brinster, 1997 Long-term culture of spermatogonial stem cells before transplantation Enrichment of stem cells before transplantation Shinohara et al., 1999 transplantation and reported that, in addition to injecting germ cells directly into the seminiferous tubules, there are two other methods of introducing donor cell suspension into the seminiferous tubules. First, the injection needle can be passed through the tunica and directly into the rete, completely filling the rete with donor cell suspension which then flows out of the rete to fill the seminiferous tubules. Second, the needle can be threaded into an efferent duct and the cell suspension injected through the duct and into the rete and tubules. It is questionable whether efferent ducts are actually entered by microinjection techniques, as is reported by Ogawa et al. (1997) . In the present authors' laboratories, rather than injecting into an efferent ductule, the efferent bundle containing the efferent ductules is used as a guide to manoeuvre the injection needle into the rete (Fig. 1) . A finely bevelled tip on the injection needle allows it to penetrate easily from the bundle into the rete. Pressure is then placed on the cell suspension in the needle, pushing it first into the rete then into the seminiferous tubules. With practice, most individuals can master the spermatogonial transplantation technique using the information provided by Ogawa et al. (1997) .
Cryopreservation of stem cells and subsequent transplantation

Spermatogonial stem cell transplantation technique and analysis
In the author's laboratory, donor germ cells are isolated from the B6,129TgR (Rosa 26) 26sor transgenic line (Jackson Laboratories), and express the Eschericia coli lacZ structural gene in nearly all cell types, including cells at all stages of spermatogenesis. Since all of the testicular cells in Rosa 26 mice express the bacterial β-galactosidase gene, analysis of the recipient testis can be done at any time after transplantation. Although qualitatively complete spermatogenesis is frequently observed in the centre of colonies at 2 months (Nagano et al., 1999) , most researchers analyse at 100 days or more. The recipient testes are typically fixed briefly in 4% paraformaldehyde, and washed and stained with X-Gal, as described by Ogawa et al. (1997) . A recipient testis and corresponding crosssection are shown (Fig. 2) .
Efficiency of transplantation
It was important to establish the optimal number of cells that should be injected to determine the efficiency of transplantation. Dobrinski et al. (1999a) used an image analysis system to quantify the degree of colonization in recipient testes following the injection of a known number of donor cells, and showed an almost linear correlation between the number of injected cells and the degree of colonization. These authors recommended the introduction of about 10 5 donor cells per recipient testis and estimated that approximately 10% of the injected stem cells colonize a recipient testis. Since the injectable volume of a mouse testis is approximately 10 µl (Dobrinski et al., 1999a; D. Johnston, unpublished) , the cells are suspended in injection media at a concentration of 10 7 cells ml -1 . Although Brinster's group has reported injecting cell concentrations as high as 10 8 cells ml -1 , the present authors' experience is that the cell suspension frequently becomes clogged in the injection needle at concentrations > 10 7 cells ml -1 and complete injection of a recipient testis at higher concentrations is rare.
There are no unique antigenic or biochemical markers of spermatogonial stem cells to permit purification before transplantation or identification after transplantation. However, there is general agreement that only the spermatogonial stem cell population is responsible for the initiation and maintenance of continuous spermatogenesis in the recipient testes. The concentration of testicular stem cells is believed to be very small, approximately 2 × 10 4 in an adult testis containing 10 8 cells (Meistrich and van Beek, 1993; Tegelenbosch and de Rooij, 1993) , or one in every 5000 cells. Spermatogenesis in a recipient testis originates from one or more small foci, and each foci is thought to arise from the successful colonization and proliferation of a single spermatogonial stem cell (Nagano et al., 1999) . Ogawa et al. (1998) reported a substantial improvement in the spermatogonial stem cell transplantation method. Over twice as many donor-derived colonies were produced in recipient animals that were treated with Leuprolide, a GnRH agonist. These findings were consistent with a report from Meistrich and Kangasniemi (1997) demonstrating that suppression of intratesticular testosterone by GnRH agonist treatment stimulated the recovery of spermatogenesis after irradiation in rats. In the study of Ogawa et al. (1998) , the increase in donorderived colonization and spermatogenesis achieved by treatment with Leuprolide represented a marked improvement in the efficiency of the transplantation system. It also provided a novel model system for investigating the effects of endocrine and paracrine factors on the establishment and progression of spermatogenesis. Fig. 1 . Spermatogonial stem cell injection. The efferent bundle is dissected and a small nick is made in it. The tip of the needle is placed into the efferent bundle and guided to the rete. When the tip of the needle enters the rete, pressure is applied to the cell suspension in the needle and it is pushed into the rete and then into the tubules.
Stimulation of spermatogenic recovery after transplantation by testosterone suppression
Demonstration using spermatogonial stem cell transplantation that germ cells control the rate of spermatogenesis
Spermatogonial transplantation has answered a long-standing question in the field of reproductive biology regarding the timing of germ cell development from spermatogonia to spermatozoa, which is regulated rigidly for each species (Russell et al., 1990; Franca et al., 1998) . For example, it takes about 35 days in mice and 52-53 days in rats for a spermatogonium to develop into a spermatozoon. It was not known whether the developmental timing is governed by germ cells, Sertoli cells, or a combination of both. Rat to mouse transplantation showed that in mice, rat germ cells develop at their characteristic rate of 52-53 days. However, in the same testis, mouse germ cells developed at the rate characteristic of mice. Thus, the somatic Sertoli cells had no influence over the rate of germ cell development. This study also showed that the mouse testes could have multiple areas of spermatogenesis developing simultaneously at different rates. This finding serves as a paradigm for other self-renewing systems in the body.
Stem cell culture before transplantation
The ultimate application of the spermatogonial stem cell technique will allow the transplantation of cultured stem cells modified genetically in vitro, yielding functional gametes with altered genotypes. At present, the greatest obstacle in achieving this goal is the development of a suitable stem cell culture system. In the past, using the identification of meiotic germ cells to determine the survival of stem cells, male germ cells have been assumed to survive in culture for, at most, only a few weeks (Kierszenbaum, 1994) . However, spermatogonial stem cell transplantation is the first functional assay that can determine whether the stem cell survives in a given culture system. used spermatogonial stem cell transplantation to demonstrate that mouse testicular stem cells could be cultured on a feeder layer of STO cells in media containing 10% fetal bovine serum for 4 months and still generate spermatogenesis successfully when transplanted into recipient mice. However, it could not be determined whether the stem cells divided during the culture period. demonstrated the value of spermatogonial stem cell transplantation in the study of testicular stem cells and nullified the long-held view that germ cells cannot survive in vitro for longer than a few weeks. This report represented an important step forward in the development of a culture system for the genetic modification of testicular stem cells in vitro.
Enhancement of transplantation efficiency by enrichment of spermatogonial stem cells
From the original studies described by Brinster and Avarbock (1994) , it was not clear whether the purification of stem cells would enhance transplant efficiency; in fact there were data supporting the contrary. The question was settled when Shinohara et al. (1999) used antibodies against β1 or α6 integrin proteins to enrich the spermatogonial stem cells. These proteins were shown to be associated with the surface of spermatogonial stem cells and, therefore, were presumed to mediate attachment to the basal lamina of the seminiferous tubule. A tenfold enrichment of spermatogonial stem cells produced up to a tenfold increase in the number of colonies formed in the recipients. This finding represented a marked improvement in spermatogonial stem cell transplant technology and indicated that the isolation of pure stem cells was the most effective means of increasing transplantation efficiency.
Kinetics of colony development
The kinetics of donor colony growth and development in mouse syngeneic transplants has been tracked in both whole-mounted (Nagano et al., 1999) and sectioned tissue (Parreira et al., 1999) . Whole mounts revealed that some cells, presumably spermatogonial stem cells, reach the basal lamina during the first week after transplantation. Colonies that can be identified as Lac Z-positive cells during the first month often appear as chains of cells. These chains of cells proliferate laterally along the basal lamina of the seminiferous tubules for about 1 month before the spermatogonia at the centre of the colony enter meiosis and translocate through the Sertoli cell junctions into 186 D. S. Johnston et al. the adluminal compartment of the tubules. Spermatogenesis expands laterally in both directions along the tubule from this site. In support of this observation, clones of spermatocytes are evident 1 month after transplantation in sectioned material. By 2 months after transplantation, mature spermatozoa are produced and, by 3 months, an average of 30% of the testiscontains donor-derived spermatogenesis. During this period of differentiation, proliferation of spermatogonia along the azoospermic tubule continues. The cumulative lateral spread of spermatogenesis in a transplanted tubule is rapid, moving at approximately 55-60 µm per day.
Hamster, dog and rabbit to mouse xenogeneic transplants
In addition to rat to mouse transplants, other interspecies transplants have been attempted. Ogawa et al. (1999) reported that hamster spermatogenesis could be produced in an immunodeficient mouse recipient. However, it was clear both qualitatively and quantitatively that hamster spermatogenesis was inferior to mouse to mouse or rat to mouse transplants. Specifically, within the seminiferous tubules, elongated spermatids with abnormal head shapes were frequently observed. Within the recipient mouse epididymis, the acrosomes of hamster spermatozoa were absent or poorly formed, and the majority of the heads and tails of hamster spermatozoa were not attached to each other. Furthermore, xenogeneic transplantations from rabbit to mouse and from dog to mouse into genetically immunodeficient mice did not produce spermatozoa successfully. The transplanted cells, although translocated to the basal compartment, remained there and did not progress. Although there probably were cell divisions, more mature cell types were not produced (Dobrinski et al., 1999b) . It was hypothesized that the success of transplants was correlated positively to the degree of evolutionary relatedness of the species. Since spermatogonia are present in the immunodeficient recipients, immunological incompatibility is not responsible for the failure of allogenic transplant success. The syngeneic and xenogeneic transplants that have been reported are listed (Table 2) together with the extents of spermatogenic development after transplantation. Since transplantation of mouse spermatogonia had been successful into species other than the mouse in instances in which immunodeficient recipients were used (Clouthier et al. 1996) , it was unclear whether spermatogenesis could be successfully initiated after allogeneic transplantation. Personal communication from Brinster's laboratory and results from the present authors' laboratories indicate that spermatogonia will seed in allogeneic mouse transplants but that they will not go forward to produce spermatogenesis. An understanding of host rejection with respect to stem cell transplantation will be important before this technology can be used for many agricultural, zoological and clinical purposes. Schlatt et al (1999) reported that they had injected germ cells into the testes of bulls, monkeys and humans that had been surgically removed. The introduction of germ cells to areas distal to the sites of injection was not achieved, presumably because endogenous spermatogenesis was not abolished before injection, and germ cells and seminiferous tubule fluid interfered with the movement of injected cells in the tubule. In all cases, the microinjection of seminiferous tubules and the cannulation of efferent ducts was inefficient. Greater success was achieved using an ultrasound-guided rete testis injection.
Injection of bull, monkey and human testes in vitro
Rete injections were performed in vivo on two cynomolgus monkeys that had been treated with the GnRH antagonist antide. The testes of one animal received dead cynomolgus testicular cells in media containing Trypan blue. In contrast with the testes from animals that have endogenous spermatogenesis, blue staining regions were observed throughout the monkey testes. The testes of the second animal were injected with live cynomolgus testicular cells that had been incubated in bromodeoxyuridine (BrdU) to permit identification at a later time. In this injection, Trypan blue was omitted from the injection media, so the flow of the cell suspension could not be monitored. However, 4 weeks after the injection, BrdU-labelled cells were found in the interstitium near the rete and also within the seminiferous tubules. The labelled cells in the seminiferous tubules were identified as type B spermatogonia and were found as single cells and as small aggregates of cells. Schlatt et al. (1999) demonstrated the first injection into human and primate testes and described a novel ultrasound guided method for direct injection of the rete.
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Additional uses of the spermatogonial stem cell transplantation technique
In addition to having numerous potential applications to preserving the germ line of valuable animals, the importance of spermatogonial stem cell transplantation technology to the study of spermatogenesis is enormous. It is a powerful technique with which to pinpoint the problematic cell type in genetic conditions affecting spermatogenesis. Specifically, the technique can be used to answer the question: 'Is the abnormality observed with spermatogenesis due to a problem with the somatic cells (for example, the Sertoli cells) or the germ cells?' For example, if a mutant has been identified in which spermatogenesis is incomplete, the germ cells could be isolated from the mutant animal and transplanted into the testis of a normal busulfan-treated animal of the same genetic background. If normal spermatogenesis occurred in the recipient, it could be assumed that the mutant had impaired Sertoli cell function leading to incomplete spermatogenesis. This conclusion could be verified by transplanting normal germ cells into a busulfan-treated mutant animal. In this example, it would be expected that spermatogenesis in the mutant animal would fail at the same point as in the untreated mutant animal. There is no doubt that laboratories throughout the world will use the spermatogonial stem cell transplantation technique to determine whether the cause of spermatogenic failure resides in germ cells or in somatic cells.
Conclusions
Since the first report of successful spermatogonial stem cell transplantation in 1994, many improvements have been made that have increased the efficiency of the technique. In addition, the technique has been valuable to basic science in the study of both the testicular stem cells and spermatogenesis. The ability to isolate the problematic cell type within sterile research animals assures greater use of this technique in the future and its tremendous potential applications to endangered species, valuable zoological and agricultural animals, and human medicine will continue to stimulate development of spermatogonial stem cell technology. At present, the primary challenges are to develop methods for obtaining pure populations of stem cells, for integrating stable exogenous DNA into these populations, and for understanding and overcoming the potential immunological responses after transplantation.
